Current market catalysts

Wells Fargo Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $235

Wells Fargo analyst Michael Turrin maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Overweight and raises the price target from $230 to $235.

8-K/A filing — YUM BRANDS INC (YUM)

Filed: 2026-08-28 AccNo: 0001041061-26-000180 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Live On CNBC, Fed's Goolsbee Says Agrees Inflation Is Fed's Main Issue Right Now; Pretty Clear That Inflation From Overheated Demand Is Hard To Address; Inflation Has Continued For Longer Than Expected; Says Was Ok With Holding Rates Steady At July FOMC; Doesn't Have Strong Opinion About Number Of FOMC Meetings; Says I’m Fine With Waiting And Seeing If Inflation Is Beginning To Head Back To 2%

Wells Fargo Maintains Equal-Weight on Elastic, Raises Price Target to $100

Wells Fargo analyst Ryan Macwilliams maintains Elastic (NYSE:ESTC) with a Equal-Weight and raises the price target from $80 to $100.

Wells Fargo Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $50

Wells Fargo analyst Michael Turrin maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the price target from $46 to $50.

Nasdaq 100 Falls As Warsh Revives Rate Hike Bets: Stock Market Today

Fed Chair Kevin Warsh said underlying inflation has not improved, pushing September hike odds to 60%, lifting the 2-year yield

Strategy Stock Drops More Than 7% as Bitcoin Pulls Back

Strategy Inc (MSTR) shares fell after $2B capital raise and Bitcoin pullback. RSI signals overbought, key support at $118.50. Analysts remain bullish.

Live On CNBC, Fed's Goolsbee Says Agreed With A Lot Of The Details Chairman Warsh Talked About On The Economy

Wells Fargo Maintains Overweight on Workday, Raises Price Target to $225

Wells Fargo analyst Michael Turrin maintains Workday (NASDAQ:WDAY) with a Overweight and raises the price target from $215 to $225.

If You Invested $1000 In NetApp Stock 10 Years Ago, You Would Have This Much Today

NetApp (NASDAQ:NTAP) has outperformed the market over the past 10 years by 4.86% on an annualized basis producing an average annual return of 18.34%. Currently, NetApp has a market capitalization of $37.41 billion.

Wells Fargo Maintains Equal-Weight on Gap, Raises Price Target to $23

Wells Fargo analyst Ike Boruchow maintains Gap (NYSE:GAP) with a Equal-Weight and raises the price target from $22 to $23.

World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report

UBS Maintains Buy on Revolution Medicines, Raises Price Target to $265

UBS analyst Michael Yee maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $220 to $265.

AI Products Accounted for More Than a Quarter of Workday's New Q2 Contract Value

Workday Q2 results highlight accelerating AI adoption, stronger subscription growth and analyst price-target increases despite reduced fiscal 2027 revenue guidance.

B. Riley Securities Maintains Buy on Nordic American Tankers, Raises Price Target to $8

B. Riley Securities analyst Liam Burke maintains Nordic American Tankers (NYSE:NAT) with a Buy and raises the price target from $7.5 to $8.

B. Riley Securities Maintains Buy on Marvell Technology, Lowers Price Target to $315

B. Riley Securities analyst Craig Ellis maintains Marvell Technology (NASDAQ:MRVL) with a Buy and lowers the price target from $345 to $315.

UBS Maintains Buy on Gap, Raises Price Target to $42

UBS analyst Jay Sole maintains Gap (NYSE:GAP) with a Buy and raises the price target from $40 to $42.

Trump Declares US Power System Emergency: 4 Stocks to Watch

President Trump declares a national emergency to secure the US bulk-power system. These 4 stocks are on watch.

UBS Maintains Buy on Elastic, Raises Price Target to $105

UBS analyst Radi Sultan maintains Elastic (NYSE:ESTC) with a Buy and raises the price target from $85 to $105.

If You Invested $100 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today

Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 21.28%. Currently, Cytokinetics has a market capitalization of $10.34

Tom Lee Says Ethereum Is ‘Vastly Undervalued,’ Could Hit $6,000 if Bitcoin Reaches $150,000

Ethereum could continue to soar due to tokenization, AI agents, and institutional adoption, making it vastly undervalued, according to Fundstrat's Tom Lee.

8-K filing — Wells Fargo Commercial Mortgage Trust 2016-LC24

Filed: 2026-08-28 AccNo: 0001888524-26-016052 Size: 36 KB Item 6.02: Change of Servicer or Trustee

UBS Maintains Neutral on Affirm Holdings, Raises Price Target to $90

UBS analyst Timothy Chiodo maintains Affirm Holdings (NASDAQ:AFRM) with a Neutral and raises the price target from $82 to $90.

UBS Maintains Neutral on SentinelOne, Raises Price Target to $24

UBS analyst Roger Boyd maintains SentinelOne (NYSE:S) with a Neutral and raises the price target from $16 to $24.

Live On CNBC, Kevin Simpson Announces Bought More CF Industries

UBS Maintains Buy on Autodesk, Raises Price Target to $325

UBS analyst Taylor McGinnis maintains Autodesk (NASDAQ:ADSK) with a Buy and raises the price target from $290 to $325.

IREN Says 2026 Capacity Sold Out — Eyes on 2027, 2028 Deals

IREN says 2026 capacity is "largely sold out" and expects strong demand for data center capacity in 2027 and 2028.

Kevin Durant Made 23,900% Profit Thanks to Nvidia, Here’s the Company That Made Him More Than NBA Salary

NBA star Kevin Durant may have just had one of his best moves ever and it wasn't on the court. Here's how much he made from one of his investments.

UBS Maintains Neutral on Choice Hotels Intl, Raises Price Target to $120

UBS analyst Robin Farley maintains Choice Hotels Intl (NYSE:CHH) with a Neutral and raises the price target from $119 to $120.

UBS Maintains Buy on StoneCo, Lowers Price Target to $13

UBS analyst Kaio Prato maintains StoneCo (NASDAQ:STNE) with a Buy and lowers the price target from $15 to $13.